Study: VEGF-A modified RNA helps convert cardiac cells into blood vessels

09/11/2013 | San Diego Union-Tribune

Researchers from Harvard University and Karolinska Institute in Stockholm converted cardiac stem cells into blood vessels using synthetic messenger RNA in the damaged hearts of mice. The study in Nature Biotechnology shows the potential of using modified RNA that codes for the protein VEGF-A in the development of new heart tissue. AstraZeneca and Moderna Therapeutics are working to develop the approach for use in patients.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT